•  
  •  
  •  
  •  

2025-10-02 08:06:58

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  EurekaForbes

Stock Report

  • Eureka Forbes Ltd enhances its manufacturing capability with a strategic partnership with Dixon Technologies (India) Ltd
  • Eureka Forbes Ltd consolidated Q4FY25 PAT higher at Rs. 49.49 crores
  • Eureka Forbes Ltd posts Rs. 47.71 crores consolidated profit in Q2 FY2024-25
  • Eureka Forbes Ltd lists shares on NSE
  • Fire incident at Eureka Forbes Limited's warehouse
  • Eureka Forbes Ltd - Financial Results for Q3 FY24
  • Eureka Forbes Ltd Q1FY24 consolidated net profit at Rs. 25.44 crores
  • Eureka Forbes Ltd posts consolidated PAT of Rs. 20.59 crores in Q4 FY2023
  • 3i Infotech Limited bags contract from Eureka Forbes Ltd
  • Advent International announces its partnership with Pratik Potato lead Eureka Forbes
  • Marzin R Shroff steps down as Managing Director and CEO of Eureka Forbes
  • Eureka Forbes Ltd consolidated Q4FY22 PAT up at Rs. 4.61 crores
  • Open offer for Eureka Forbes Ltd at Rs. 210.15 per share

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024